Table 1

Percentage of self-reported chronic conditions among older adults aged 45 years and over by condition and by body system

nPrevalence (95% CI)
Morbidity
 Cancer*87 38634.7 (34.5 to 34.9)
 Heart disease†32 69013.0 (12.9 to 13.1)
 Diabetes22 5759.0 (8.9 to 9.1)
 Parkinson’s disease15660.6 (0.6 to 0.7)
 Stroke78933.1 (3.1 to 3.2)
 Depression or anxiety46 34318.4 (18.3 to 18. 6)
 Asthma‡31 31612.4 (12.3 to 12.6)
 Allergic rhinitis‡34 50913.7 (13.6 to 13.9)
 Hypertension78 13531.0 (30.9 to 31.2)
 Thrombosis13 8345.5 (5.4 to 5.6)
 Musculoskeletal conditions§29 98611.9 (11.8 to 12.0)
 Multimorbidity (≥2 morbidities)111 08444.1 (43.9 to 44.3)
Body system morbidity: any conditions within these systems¶
 Cardiovascular128 06950.9 (50.7 to 51.1)
 Musculoskeletal35 27214.0 (13.9 to 14.2)
 Neurological15660.6 (0.6 to 0.7)
 Psychological46 34318.4 (18.3 to 18. 6)
 Respiratory55 27922.0 (21.8 to 22.1)
 Skin13 8115.5 (5.4 to 5.6)
 Endocrine/metabolic33 53313.3 (13.2 to 13.5)
 F genital**73002.9 (2.8 to 3.0)
 M genital††23 8509.5 (9.4 to 9.6)
 Complex multimorbidity (≥3 body system)39 47815.7 (15.5 to 15.8)
  • *Cancer includes melanoma, breast cancer (F), prostate cancer (M) and other cancer.

  • †Heart disease includes heart attack, angina or other heart disease.

  • ‡Asthma and allergic rhinitis were collected as aggregated for the first ~15% people, but they were separated for the remaining people.

  • §Musculoskeletal includes osteoarthritis, osteoporosis or low bone density.

  • ¶Body system morbidities: cardiovascular includes heart disease, high blood pressure, blood clot (thrombosis), heart attack or angina and other heart disease; musculoskeletal includes osteoarthritis, osteoporosis or low bone density; neurological includes Parkinson’s disease; psychological includes depression or anxiety; respiratory includes asthma or allergic rhinitis; skin includes melanoma; endocrine/metabolic includes diabetes and thyroid problems; F genital includes breast cancer; M genital includes prostate cancer or enlarged prostate.

  • **Denominator for this estimate was the total number of F participants.

  • ††Denominator for this estimate was the total number of M participants.

  • F, female; M, male.